A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk

Clinical trial NCT07613294 · RECRUITING

Trial details

NCT number: NCT07613294
Sponsor: Eli Lilly and Company
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Atherosclerosis Cardiovascular Diseases Lipoprotein(a)

Start date: 2026-06-01
Primary completion: 2029-12-01
Enrollment: 252

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.